Oncolytics Biotech (ONCY) Posts Q1 Loss of 6c/Share
Oncolytics Biotech (NASDAQ: ONCY) reported Q1 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.
